Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-08 Sale | 2023-11-08 8:32 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 3,163 | $0.33 | $1,044 | 32,357 (Direct) | View |
| 2023-11-02 Sale | 2023-11-03 4:12 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 6,854 | $0.33 | $2,262 | 47,270 (Direct) | View |
| 2023-08-08 Sale | 2023-08-09 8:44 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 3,128 | $9.51 | $29,747 | 29,874 (Direct) | View |
| 2023-05-23 Sale | 2023-06-12 4:01 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 22,571 | $0.1418 | $3,201 | 262,557 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:31 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 68,014 | $0.1255 | $8,536 | 285,128 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-07 Exercise | 2023-11-08 8:32 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 6,625 | $0 | 32,357 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 4:12 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 12,500 | $0 | 47,270 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 8:55 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 8:44 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 6,625 | $0 | 29,874 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:08 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 132,500 | $0 | 750,642 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:32 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 530,000 | $0 | 530,000 (Direct) | View |
| 2022-01-19 Option Award | 2022-01-21 4:50 pm | N/A 2032-01-19 | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 125,000 | $0 | 125,000 (Direct) | View |
| 2021-01-27 Option Award | 2021-01-29 5:32 pm | N/A 2031-01-27 | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 179,000 | $0 | 179,000 (Direct) | View |
| 2020-01-28 Option Award | 2020-01-30 4:20 pm | N/A 2030-01-27 | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 100,000 | $0 | 100,000 (Direct) | View |